Mapping the road to biologics in psoriasis and psoriatic arthritis: A nationwide drug utilization study von Thein, David, Rosenø, Nana A. L., Nielsen, Mia‐Louise, Kristensen, Lars Erik, Maul, Julia‐Tatjana, Wu, Jashin J., Thomsen, Simon Francis, Thyssen, Jacob P., Egeberg, Alexander

Volltext

Exploring disease comorbidities and temporal disease progression of psoriasis: an observational, retrospective, multi-database, cohort study von Rosenø, Nana A L, Lørup, Erik Hillo, Richardson, Craig, Alarcon, Ivette, Egeberg, Alexander

Volltext

Drug survival of biologics in hidradenitis suppurativa: A systematic review and meta-analysis von Pham, James P., Rosenø, Nana A.L., Roccuzzo, Gabriele, Saal, Ryan C., Egeberg, Alexander, Ring, Hans C., Frew, John W.

Volltext

Drug Survival of Adalimumab, Secukinumab, and Ustekinumab in Psoriasis as Determined by Either Dose Escalation or Drug Discontinuation during the First 3 Years of Treatment – a Nat... von Thein, David, Rosenø, Nana A.L., Maul, Julia-Tatjana, Wu, Jashin J., Skov, Lone, Bryld, Lars Erik, Rasmussen, Mads K., Ajgeiy, Kawa Khaled, Thomsen, Simon Francis, Thyssen, Jacob P., Egeberg, Alexander

Volltext

Adherence to therapy of ixekizumab and secukinumab in psoriatic arthritis patients using first- or second-line IL-17A inhibitor treatment: a Danish population-based cohort study von Hansen, Rebekka L, Jørgensen, Tanja S, Egeberg, Alexander, Rosenø, Nana A L, Skougaard, Marie, Stisen, Zara R, Dreyer, Lene, Kristensen, Lars Erik

Volltext